Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02722382 · ClinicalTrials.gov registry record · NA
Putting Patients at the Center of Kidney Care Transitions (PREPARE NOW)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 1,572
- Enrollment target
NCT02722382: Completed NA study, sponsored by Duke University.
NCT02722382 is a NA study that has completed, run by Duke University. The registered enrollment target is 1,572 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (12% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02722382, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,572 participants
- Enrollment target
Study Summary
Objective: The investigators will change the health system to improve care patients receive as they transition through earlier stages of kidney disease toward kidney failure. They will study whether these changes lead to patients' improved health and well-being. Methods: The investigators will conduct this study in Geisinger Health System kidney specialty clinics. The study will implement 'Patient Centered Kidney Transitions Care' which will (1) give doctors tools to help them recognize when patients should prepare for kidney failure and help them support patients' early and informed treatment decisions; and (2) add a 'Kidney Transitions Specialist' to the health care team to help patients learn about kidney disease, learn self-care skills, make informed decisions, get psychosocial support, and coordinate their care. Four (4) clinics will be randomly assigned to provide Patient Centered Kidney Transitions Care, and four (4) to provide their usual care. The investigators will study differences in patients' outcomes among those treated in clinics providing Patient Centered Kidney Transitions Care compared to those treated in clinics providing usual care. Patient Outcomes: Patients have told us they want to have 'control' over their disease transitions and to have the best quality of life possible. The investigators will measure patients' empowerment, confidence with their self-care, their decisions to start self-care treatments for kidney failure, and their hospitalizations. They will also measure whether doctors record patients' treatment preferences in the medical record before patients develop kidney failure. Patient and Stakeholder Engagement: This study responds to reports from hundreds of patients and caregivers who want better care. Patients and caregivers from around the US are part of our investigative team, and they will participate in all aspects of our study. The investigators are also engaging key stakeholders in the kidney community, including patient
Primary Outcome
Change in % patients feeling in control of their decision-making
Interventions
- OTHER Patient-Centered Kidney Transitions Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,572 participants |
| Start Date | 2017-01-31 |
| Est. Completion | 2020-10-31 |
| Phase | NA |
What the finished NCT02722382 record still lists
NCT02722382 is an interventional study that assigns participants to a tested intervention. Its 1,572 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (12% higher).
The record links to 0 conditions, and to 1 intervention - of which Patient-Centered Kidney Transitions Care is the first listed.
NCT02722382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02722382 about?
NCT02722382 is a clinical study titled "Putting Patients at the Center of Kidney Care Transitions (PREPARE NOW)". Objective: The investigators will change the health system to improve care patients receive as they transition through earlier stages of kidney disease toward kidney failure. They will study whether these changes lead to patients' improved health and well-being. Methods: The investigators will cond...
What is the current status of trial NCT02722382?
This trial is currently completed. It is a NA study. The enrollment target is 1,572 participants. The study started on 2017-01-31. Estimated completion is 2020-10-31.
What interventions are being tested in trial NCT02722382?
The interventions under investigation include: Patient-Centered Kidney Transitions Care (OTHER).
Who is sponsoring clinical trial NCT02722382?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02722382's enrollment target sits among peer trials
1,572 64th of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI